This observation is in contrast with data from Luchetti et al. [32], who demonstrated an increase in aromatase mRNA expression in the prefrontal cortex of patients diagnosed with AD that coincided with an increase in the number of aromatase-immunoreactive astrocytes in this region. The gene discussed is CYP19A1; the disease is Alzheimer disease.